Literature DB >> 10081498

A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.

T Hasebe1, S Imoto, S Sasaki, K Mukai.   

Abstract

Tumor recurrence rate (TRR) and mortality rate (MR) of invasive ductal carcinoma (IDC) of the breast in short-term follow-up are relatively low. Nevertheless, it is extremely important to identify patients at risk of early recurrence or death after surgery. The aim of this study was to establish a new histological prognostic classification scheme for IDC in order accurately to predict the short-term outcome. The following histological parameters were analyzed in 201 IDCs: 1) tumor size, 2) structural atypia, 3) nuclear atypia, 4) number of mitotic figures, 5) fibrotic focus (FF), 6) vascular invasion, 7) tumor necrosis, 8) skin invasion, 9) muscle invasion, 10) nodal status and 11) extramammary fat invasion. Multivariate analysis showed that nuclear atypia, presence of FF, and the invasive length of fat invasion (ILFI) were the most important histological parameters correlated with TRR or MR of IDCs. Accordingly, a new histological classification based on nuclear atypia, FF and ILFI (Nucleus-Fibrotic focus-Fat invasion, NFF) was devised. Comparative studies were performed with the following existing prognostic classifications: 1) histological grade, 2) modified Scarff-Bloom-Richardson histological grade, 3) prognostic index and 4) pathological TNM (pTNM) stage classifications. Patient grouping defined by NFF classification significantly correlated with tumor recurrence or death of IDCs in all cases, cases at stages I and II, those without lymph node metastasis and those who were estrogen receptor (ER)-positive after adjustment for the other four classifications, using multivariate analysis. NFF classification appeared superior to existing prognostic classifications for the accurate prediction of the short-term outcome for patients with IDCs in low risk groups.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10081498      PMCID: PMC5921741          DOI: 10.1111/j.1349-7006.1998.tb00534.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

1.  Editorial: Hazards in the use of the logistic function with special reference to data from prospective cardiovascular studies.

Authors:  T Gordon
Journal:  J Chronic Dis       Date:  1974-03

2.  Prognostic significance of accumulation of gene and chromosome alterations and histological grade in node-negative breast carcinoma.

Authors:  H Tsuda; C Sakamaki; S Tsugane; T Fukutomi; S Hirohashi
Journal:  Jpn J Clin Oncol       Date:  1998-01       Impact factor: 3.019

3.  Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions.

Authors:  J A Uría; M Ståhle-Bäckdahl; M Seiki; A Fueyo; C López-Otín
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

4.  Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; T Hirota; S Tsugane; H Yamamoto; N Miyajima; K Toyoshima; T Yamamoto; J Yokota
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

5.  Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.

Authors:  F Courjal; M Cuny; J Simony-Lafontaine; G Louason; P Speiser; R Zeillinger; C Rodriguez; C Theillet
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

6.  Prognostic factors in patients with stage I, estrogen receptor-negative carcinoma of the breast. A clinicopathologic study.

Authors:  T W Bauer; D O'Ceallaigh; J C Eggleston; G W Moore; R R Baker
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

Review 7.  Follow-up study of HER-2/neu amplification in primary breast cancer.

Authors:  G M Clark; W L McGuire
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

8.  Microsatellite instability is correlated with lymph node-positive breast cancer.

Authors:  L De Marchis; A Contegiacomo; C D'Amico; R Palmirotta; C Pizzi; L Ottini; P Mastranzo; M Figliolini; G Petrella; C Amanti; P Battista; A R Bianco; L Frati; A Cama; R Mariani-Costantini
Journal:  Clin Cancer Res       Date:  1997-02       Impact factor: 12.531

9.  Prognostic significance of DNA measurements in 409 consecutive breast cancer patients.

Authors:  A G Fallenius; G U Auer; J M Carstensen
Journal:  Cancer       Date:  1988-07-15       Impact factor: 6.860

10.  Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells.

Authors:  T Inoue; Y S Chung; M Yashiro; S Nishimura; T Hasuma; S Otani; M Sowa
Journal:  Jpn J Cancer Res       Date:  1997-02
View more
  1 in total

Review 1.  Adipocytes: impact on tumor growth and potential sites for therapeutic intervention.

Authors:  Simona Hefetz-Sela; Philipp E Scherer
Journal:  Pharmacol Ther       Date:  2013-01-24       Impact factor: 12.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.